Trademark Overview
On Tuesday, October 21, 2025, a trademark application was filed for TAHLOBRY with the United States Patent and Trademark Office. The USPTO has given the TAHLOBRY trademark a serial number of 99454077. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, February 26, 2026. This trademark is owned by Merck Sharp & Dohme B.V.. The TAHLOBRY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
